Pharmaceuticals Inc. (NASDAQ:INFI) reported a loss of 68 cents per share in the fourth quarter of 2013, narrower than the Zacks Consensus Estimate of a loss of 83 cents and the year-ago loss of $1.15 per share. The narrower loss was attributable to lower operating expenses. Infinity Pharma’s shares soared more than 15.5% following the fourth quarter results. Infinity Pharmaceuticals Inc. (NASDAQ:INFI) shares after opening at $11.34 moved to $11.38 on last trade day and at the end of the day closed at $10.95. Company price to cash ratio is 2.47. Infinity Pharmaceuticals Inc. (NASDAQ:INFI) showed a negative weekly performance of 14.79%.
Ceres Inc. (NASDAQ:CERE), an agricultural biotechnology and seed company, announced that it will report financial results for the second quarter of fiscal year 2014 on Thursday, April 10, 2014 after the close of the market. The company has scheduled a webcast and conference call for 4:30 p.m. EDT (1:30 p.m. PDT) to discuss its fiscal second quarter results and to provide an update on its business. Ceres Inc. (NASDAQ:CERE) shares fell 6.57% in last trading session and ended the day on $0.810. Ceres Inc. (NASDAQ:CERE) return on equity ratio is recorded as -111.20% and its return on assets is -98.10%. Ceres Inc. (NASDAQ:CERE) yearly performance is -76.92%.
Investors inMomenta Pharmaceuticals, Inc. (NASDAQ:MNTA) were disappointed when the Supreme Court decided to hear an appeal by Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA). The decision will mean that Momenta will have to delay the launch of their own generic version of Copaxone. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shares moved down 3.81% in last trading session and was closed at $11.11, while trading in range of $ 10.83 – 12.13. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) year to date (YTD) performance is -37.16%.
The chief financial officer of CHC Helicopter will be meeting with investors and analysts at a premier energy-investment conference. CHC Group Ltd. (NYSE:HELI) weekly performance is 1.35%. On last trading day company shares ended up $7.50. CHC Group Ltd. (NYSE:HELI) distance from 50-day simple moving average (SMA50) is -14.60%. Analysts mean target Price for the company is $12.43.